THE US Food and Drug Administration has approved several strengths of potassium chloride oral solution, as the first items to receive a Competitive Generic Therapy (CGT) designation.
The new pathway was created to expedite the development and review of generic versions of pharmaceutical products that lack competition.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Aug 18
